07:00 , Mar 24, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Autoimmune disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Autoimmune disease Rheumatoid arthritis (RA) Progranulin (PGRN); tumor necrosis factor-a (TNF-a); tumor necrosis factor receptor 1 (TNFRSF1A; TNFR1; CD120a); TNFR2 In vitro...
07:00 , Mar 24, 2011 |  BC Innovations  |  Cover Story

New front against TNF

New York University School of Medicine...